ReviewDiabetology & metabolic syndrome2025

Comparative risk of cancer associated with SGLT inhibitors and DPP-4 inhibitors in patients with diabetes: a systematic review and meta-analysis.

Hamed Hajishah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.